Company intelligence / Profile preview

Asahi Kasei Corporation

Overview

Maintains top market shares in hemodialysis, therapeutic apheresis, transfusion therapy, and virus removal for biotherapeutic products[4]

1 asset

Pre-clinical

Previously had a joint petrochemical venture with Dow Chemical[3]

Beyond the preview

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Follow clinical development from trial design and recruitment through results.

Explore licensing agreements, acquisitions, and the assets behind each deal.

Trace financing activity and the investors behind a company’s development.

Compare peer pipelines by target, modality, and therapeutic area.

Explore technology platforms and the patent landscape around relevant assets.

Connect company news and source material to the questions you’re investigating.

See how Gosset can support your research on Asahi Kasei Corporation.